Global Lung Cancer Market Growth (Status and Outlook) 2024-2030

December 2024 | 84 pages | ID: G9D010228D49EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Lung Cancer market size was valued at US$ 19030 million in 2023. With growing demand in downstream market, the Lung Cancer is forecast to a readjusted size of US$ 32580 million by 2030 with a CAGR of 8.0% during review period.

The research report highlights the growth potential of the global Lung Cancer market. Lung Cancer are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lung Cancer. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lung Cancer market.

Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.

Lung cancer is the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.

Key Features:

The report on Lung Cancer market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Lung Cancer market. It may include historical data, market segmentation by Type (e.g., Surgery, Chemotherapy), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lung Cancer market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Lung Cancer market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Lung Cancer industry. This include advancements in Lung Cancer technology, Lung Cancer new entrants, Lung Cancer new investment, and other innovations that are shaping the future of Lung Cancer.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lung Cancer market. It includes factors influencing customer ' purchasing decisions, preferences for Lung Cancer product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lung Cancer market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lung Cancer market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lung Cancer market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lung Cancer industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lung Cancer market.

Market Segmentation:

Lung Cancer market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Surgery
• Chemotherapy
• Radiotherapy
• Photodynamic Therapy
• Laser Therapy

Segmentation by application

• Hospital & Clinics
• Cancer Research Centers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• Novartis
• Pfizer
• Merck
• Bristol-Myers Squibb
• Eli Lilly And Company
• Sanof

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Lung Cancer Market Size 2019-2030
  2.1.2 Lung Cancer Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Lung Cancer Segment by Type
  2.2.1 Surgery
  2.2.2 Chemotherapy
  2.2.3 Radiotherapy
  2.2.4 Photodynamic Therapy
  2.2.5 Laser Therapy
2.3 Lung Cancer Market Size by Type
  2.3.1 Lung Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Lung Cancer Market Size Market Share by Type (2019-2024)
2.4 Lung Cancer Segment by Application
  2.4.1 Hospital & Clinics
  2.4.2 Cancer Research Centers
  2.4.3 Others
2.5 Lung Cancer Market Size by Application
  2.5.1 Lung Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Lung Cancer Market Size Market Share by Application (2019-2024)

3 LUNG CANCER MARKET SIZE BY PLAYER

3.1 Lung Cancer Market Size Market Share by Players
  3.1.1 Global Lung Cancer Revenue by Players (2019-2024)
  3.1.2 Global Lung Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Lung Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LUNG CANCER BY REGIONS

4.1 Lung Cancer Market Size by Regions (2019-2024)
4.2 Americas Lung Cancer Market Size Growth (2019-2024)
4.3 APAC Lung Cancer Market Size Growth (2019-2024)
4.4 Europe Lung Cancer Market Size Growth (2019-2024)
4.5 Middle East & Africa Lung Cancer Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Lung Cancer Market Size by Country (2019-2024)
5.2 Americas Lung Cancer Market Size by Type (2019-2024)
5.3 Americas Lung Cancer Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Lung Cancer Market Size by Region (2019-2024)
6.2 APAC Lung Cancer Market Size by Type (2019-2024)
6.3 APAC Lung Cancer Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Lung Cancer by Country (2019-2024)
7.2 Europe Lung Cancer Market Size by Type (2019-2024)
7.3 Europe Lung Cancer Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Lung Cancer by Region (2019-2024)
8.2 Middle East & Africa Lung Cancer Market Size by Type (2019-2024)
8.3 Middle East & Africa Lung Cancer Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LUNG CANCER MARKET FORECAST

10.1 Global Lung Cancer Forecast by Regions (2025-2030)
  10.1.1 Global Lung Cancer Forecast by Regions (2025-2030)
  10.1.2 Americas Lung Cancer Forecast
  10.1.3 APAC Lung Cancer Forecast
  10.1.4 Europe Lung Cancer Forecast
  10.1.5 Middle East & Africa Lung Cancer Forecast
10.2 Americas Lung Cancer Forecast by Country (2025-2030)
  10.2.1 United States Lung Cancer Market Forecast
  10.2.2 Canada Lung Cancer Market Forecast
  10.2.3 Mexico Lung Cancer Market Forecast
  10.2.4 Brazil Lung Cancer Market Forecast
10.3 APAC Lung Cancer Forecast by Region (2025-2030)
  10.3.1 China Lung Cancer Market Forecast
  10.3.2 Japan Lung Cancer Market Forecast
  10.3.3 Korea Lung Cancer Market Forecast
  10.3.4 Southeast Asia Lung Cancer Market Forecast
  10.3.5 India Lung Cancer Market Forecast
  10.3.6 Australia Lung Cancer Market Forecast
10.4 Europe Lung Cancer Forecast by Country (2025-2030)
  10.4.1 Germany Lung Cancer Market Forecast
  10.4.2 France Lung Cancer Market Forecast
  10.4.3 UK Lung Cancer Market Forecast
  10.4.4 Italy Lung Cancer Market Forecast
  10.4.5 Russia Lung Cancer Market Forecast
10.5 Middle East & Africa Lung Cancer Forecast by Region (2025-2030)
  10.5.1 Egypt Lung Cancer Market Forecast
  10.5.2 South Africa Lung Cancer Market Forecast
  10.5.3 Israel Lung Cancer Market Forecast
  10.5.4 Turkey Lung Cancer Market Forecast
  10.5.5 GCC Countries Lung Cancer Market Forecast
10.6 Global Lung Cancer Forecast by Type (2025-2030)
10.7 Global Lung Cancer Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Lung Cancer Product Offered
  11.1.3 Roche Lung Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Lung Cancer Product Offered
  11.2.3 Novartis Lung Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Lung Cancer Product Offered
  11.3.3 Pfizer Lung Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Merck
  11.4.1 Merck Company Information
  11.4.2 Merck Lung Cancer Product Offered
  11.4.3 Merck Lung Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Merck Main Business Overview
  11.4.5 Merck Latest Developments
11.5 Bristol-Myers Squibb
  11.5.1 Bristol-Myers Squibb Company Information
  11.5.2 Bristol-Myers Squibb Lung Cancer Product Offered
  11.5.3 Bristol-Myers Squibb Lung Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Bristol-Myers Squibb Main Business Overview
  11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Eli Lilly And Company
  11.6.1 Eli Lilly And Company Company Information
  11.6.2 Eli Lilly And Company Lung Cancer Product Offered
  11.6.3 Eli Lilly And Company Lung Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Eli Lilly And Company Main Business Overview
  11.6.5 Eli Lilly And Company Latest Developments
11.7 Sanof
  11.7.1 Sanof Company Information
  11.7.2 Sanof Lung Cancer Product Offered
  11.7.3 Sanof Lung Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Sanof Main Business Overview
  11.7.5 Sanof Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Lung Cancer Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Surgery
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Radiotherapy
Table 5. Major Players of Photodynamic Therapy
Table 6. Major Players of Laser Therapy
Table 7. Lung Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Lung Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Lung Cancer Market Size Market Share by Type (2019-2024)
Table 10. Lung Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Lung Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Lung Cancer Market Size Market Share by Application (2019-2024)
Table 13. Global Lung Cancer Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Lung Cancer Revenue Market Share by Player (2019-2024)
Table 15. Lung Cancer Key Players Head office and Products Offered
Table 16. Lung Cancer Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Lung Cancer Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Lung Cancer Market Size Market Share by Regions (2019-2024)
Table 21. Global Lung Cancer Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Lung Cancer Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Lung Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Lung Cancer Market Size Market Share by Country (2019-2024)
Table 25. Americas Lung Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Lung Cancer Market Size Market Share by Type (2019-2024)
Table 27. Americas Lung Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Lung Cancer Market Size Market Share by Application (2019-2024)
Table 29. APAC Lung Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Lung Cancer Market Size Market Share by Region (2019-2024)
Table 31. APAC Lung Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Lung Cancer Market Size Market Share by Type (2019-2024)
Table 33. APAC Lung Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Lung Cancer Market Size Market Share by Application (2019-2024)
Table 35. Europe Lung Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Lung Cancer Market Size Market Share by Country (2019-2024)
Table 37. Europe Lung Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Lung Cancer Market Size Market Share by Type (2019-2024)
Table 39. Europe Lung Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Lung Cancer Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Lung Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Lung Cancer Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Lung Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Lung Cancer Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Lung Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Lung Cancer Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Lung Cancer
Table 48. Key Market Challenges & Risks of Lung Cancer
Table 49. Key Industry Trends of Lung Cancer
Table 50. Global Lung Cancer Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Lung Cancer Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Lung Cancer Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Lung Cancer Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Roche Details, Company Type, Lung Cancer Area Served and Its Competitors
Table 55. Roche Lung Cancer Product Offered
Table 56. Roche Lung Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Novartis Details, Company Type, Lung Cancer Area Served and Its Competitors
Table 60. Novartis Lung Cancer Product Offered
Table 61. Novartis Main Business
Table 62. Novartis Lung Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Novartis Latest Developments
Table 64. Pfizer Details, Company Type, Lung Cancer Area Served and Its Competitors
Table 65. Pfizer Lung Cancer Product Offered
Table 66. Pfizer Main Business
Table 67. Pfizer Lung Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Pfizer Latest Developments
Table 69. Merck Details, Company Type, Lung Cancer Area Served and Its Competitors
Table 70. Merck Lung Cancer Product Offered
Table 71. Merck Main Business
Table 72. Merck Lung Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Merck Latest Developments
Table 74. Bristol-Myers Squibb Details, Company Type, Lung Cancer Area Served and Its Competitors
Table 75. Bristol-Myers Squibb Lung Cancer Product Offered
Table 76. Bristol-Myers Squibb Main Business
Table 77. Bristol-Myers Squibb Lung Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Bristol-Myers Squibb Latest Developments
Table 79. Eli Lilly And Company Details, Company Type, Lung Cancer Area Served and Its Competitors
Table 80. Eli Lilly And Company Lung Cancer Product Offered
Table 81. Eli Lilly And Company Main Business
Table 82. Eli Lilly And Company Lung Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Eli Lilly And Company Latest Developments
Table 84. Sanof Details, Company Type, Lung Cancer Area Served and Its Competitors
Table 85. Sanof Lung Cancer Product Offered
Table 86. Sanof Main Business
Table 87. Sanof Lung Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Sanof Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Lung Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lung Cancer Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Lung Cancer Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Lung Cancer Sales Market Share by Country/Region (2023)
Figure 8. Lung Cancer Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Lung Cancer Market Size Market Share by Type in 2023
Figure 10. Lung Cancer in Hospital & Clinics
Figure 11. Global Lung Cancer Market: Hospital & Clinics (2019-2024) & ($ Millions)
Figure 12. Lung Cancer in Cancer Research Centers
Figure 13. Global Lung Cancer Market: Cancer Research Centers (2019-2024) & ($ Millions)
Figure 14. Lung Cancer in Others
Figure 15. Global Lung Cancer Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Lung Cancer Market Size Market Share by Application in 2023
Figure 17. Global Lung Cancer Revenue Market Share by Player in 2023
Figure 18. Global Lung Cancer Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Lung Cancer Market Size 2019-2024 ($ Millions)
Figure 20. APAC Lung Cancer Market Size 2019-2024 ($ Millions)
Figure 21. Europe Lung Cancer Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Lung Cancer Market Size 2019-2024 ($ Millions)
Figure 23. Americas Lung Cancer Value Market Share by Country in 2023
Figure 24. United States Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Lung Cancer Market Size Market Share by Region in 2023
Figure 29. APAC Lung Cancer Market Size Market Share by Type in 2023
Figure 30. APAC Lung Cancer Market Size Market Share by Application in 2023
Figure 31. China Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Lung Cancer Market Size Market Share by Country in 2023
Figure 38. Europe Lung Cancer Market Size Market Share by Type (2019-2024)
Figure 39. Europe Lung Cancer Market Size Market Share by Application (2019-2024)
Figure 40. Germany Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Lung Cancer Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Lung Cancer Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Lung Cancer Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Lung Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 54. APAC Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 55. Europe Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 57. United States Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 58. Canada Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 61. China Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 62. Japan Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 63. Korea Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 65. India Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 66. Australia Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 67. Germany Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 68. France Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 69. UK Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 70. Italy Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 71. Russia Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 72. Spain Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 75. Israel Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Lung Cancer Market Size 2025-2030 ($ Millions)
Figure 78. Global Lung Cancer Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Lung Cancer Market Size Market Share Forecast by Application (2025-2030)